Congratulations to Prof. Abdoulaye Djimde this well deserved and timely recognition as one of the leading Global Health figures by European & Developing Countries Clinical Trials Partnership (Global Health EDCTP3).
His outstanding contributions to malaria research and clinical trials continue to shape the future of treatment in Africa and beyond.
Through his leadership of WANECAM , he has advanced groundbreaking work on antimalarial drugs.
This recognition highlights his unwavering commitment to strengthening health research capacity.
May this achievement open the door to even greater impact and continued success.
Similar Posts
The Structural Biology Initiation Workshop co-initiated by BIO-STRUCTURE and WANECAM 2
Context : Most African countries do not conduct research in structural biology due to limited resources, lack of trained people and brain drain of qualified scientists. Thus WANECAM 2 and BIO-STRUCT organised a training workshop in Structural Biology in the Bioinformatics Room of DELGEME in Bamako, Mali from 25 to 28 April 2022. The opening…
Fifth Hideyo Noguchi Africa Prize – Tokyo, August 22, 2025
On August 22, 2025, in the gracious presence of Their Majesties the Emperor and Empress of Japan, Professor Abdoulaye Djimdé received the Fifth Hideyo Noguchi Africa Prize, presented by Prime Minister Ishiba during a solemn ceremony held in Tokyo. Our warmest congratulations to Professor Abdoulaye Djimdé for this prestigious distinction, which celebrates African research and…
Owards the First Non-Artemisinin Combinations for Plasmodium falciparum Malaria
On November 13, 2025, the WANECAM 2 project organized a Symposium during the Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) held in Toronto, Canada. The presenters included Prof. Abdoulaye Djimde, Montserrat Blazquez-Domingo (EDCTP Representative), Cornelis Winnips, Martin Grobusch, and Fatim Ballo. Entitled “Towards the First Non-artemisinin Combinations for falciparum Malaria:…
WANECAM 2: Congress and Project Management Board Meeting in Libreville, Gabon
The annual WANECAM 2 congress, combined with a Project Management Board meeting, took place on December 4-5, 2024, at the Hôtel Boulevard in Libreville, Gabon. The event was attended by Prof. Abdoulaye Djimdé, coordinator of the consortium, Dr. Rella Manego, principal investigator for the Gabonese site, and Prof. Ghyslain Mombongoma. Highlights of the Meeting Outlook…
WANECAM2 consortium reports positive results from Phase 2b study of novel treatment for children with malaria
New Orleans, 15 November 2024 – The West African Network for Clinical Trials of Antimalarial Drugs (WANECAM2) consortium is pleased to announce positive results from the Phase 2b KALUMI study of the novel, non-artemisinin drug ganaplacide combined with a new once-daily formulation of lumefantrine. KALUMI is a Phase 2 randomized, open-label, non-inferiority study evaluating the…
Workshop for enhancing the PhD research of the Malaria Research and Training Center (MRTC-Parasito), organized by WANECAM 2
Context As part of its capacity building activities, WANECAM 2 initiated a workshop for its PhDs students and extended to all MRTC-Parasito PhDs to review their thesis work. This in order to better formalize their supervision and enhance the quality of human resources trained locally at MRTC-Parasito. Objectives This activity took place from 19 to…
